Le Lézard
Classified in: Health
Subject: SVY

EHE Health Completes Study Citing Prevention as Source of Lower Healthcare Costs


These insights are beneficial for self-insured employers of all sizes and demonstrate the value of adult preventive care compared to traditional primary care.

NEW YORK, April 11, 2024 /PRNewswire/ -- EHE Health is excited to share results from a two-year analysis demonstrating the power of comprehensive preventive care. The study shows that engagement with EHE Health achieves 14% reduction in total cost of care, 26% reduction in emergency room utilization, and >35% fewer inpatient admissions. The analysis was conducted for multiple national employers to measure the impact of comprehensive preventive exams, and how they affect healthcare costs, utilization, and overall quality.

"We are very proud of the time and focus our company devotes entirely to preventive healthcare and the results speak for themselves," Chris Bird, CEO, added. "EHE Health stands in sharp contrast to today's primary care model comprised of short visits, high volumes, and inherently biased acute patient needs. Preventive care needs to be a bigger priority in this county if we want to meaningfully improve patient utilization, outcomes, and costs."

The study, which analyzed working age adults (ages 25 through 64 years old), was designed to compare the health status, engagement, and health outcomes of EHE Health users to non-users. This study demonstrates that EHE Health's adult preventive care outperforms traditional primary care and delivers more member value through more complete preventive services.

The study also demonstrates the EHE Health program delivers 46% fewer incidents of high-cost claimants overall. These results are especially crucial for self-insured employers looking to navigate and control their high-cost claims. The impact of high-cost claims is substantial, with less than 1% of members often accounting for over 25% of total healthcare costs. In many instances, by the time these cases get the attention of the employer, or its third-party administrator (TPA), a significant portion of the total costs associated with these claimants may have already been incurred.

Eric Tolkin, Chief Business Development Officer at EHE, is looking forward to sharing the study with clients and prospects. "At EHE, we are constantly asked by prospective clients how EHE Health can save them money," he said. "Thanks to this comprehensive study, we now can provide proof that, by offering their insured employees comprehensive preventive exams, companies will realize significant savings, along with increased utilization. Plus, they will have happier, and healthier employees."

For more information, visit www.ehe.health/for-employers 

About EHE Health

EHE Health is a leading national provider network specializing in preventive healthcare services. EHE Health partners with mid- to large-sized employers to offer their employees and beneficiaries access to comprehensive healthcare beginning with prevention. Recognized as one of the Best Workplaces in healthcare by Fortune Magazine and Great Place to Work®, EHE Health is headquartered in New York City and has over 200 health clinics nationwide that are staffed by a carefully selected network of primary care physicians and clinicians. With a legacy of over 100 years, EHE Health continues to innovate and lead in personalized preventive care, helping individuals live longer, healthier lives. For more information, visit us at www.ehe.health.

SOURCE EHE Health


These press releases may also interest you

at 08:15
OmniAb, Inc. today announced that management will be participating in five investor conferences during the month of May. RBC Capital Markets Global Healthcare Conference, May 14-15 at the InterContinental Barclay Hotel in New York City....

at 08:15
Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced it will present preclinical proof-of-concept data for the company's MTAC (M6PR Targeting Chimera) protein degrader platform at IMMUNOLOGYtm...

at 08:15
VantAI, a pioneer in generative AI-enabled drug discovery, is working with Google Cloud to power large scale distributed training and further improve internal operations. This collaboration is set to provide VantAI with NVIDIA H100 GPUs, a move that...

at 08:10
NOMADX Holdings LLC ("NOMADX Holdings"), a private company pioneering new technologies for biological and chemical detection, announced today that it has commenced operations to commercialize a portfolio of innovative products that will enable...

at 08:10
Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the first quarter ended March 31, 2024 before...

at 08:10
Combined Canada, a leading provider of supplemental accident, health, disability, and life insurance products in Canada, today introduced a new suite of products designed to address a prominent gap in the Canadian marketplace?critical illness...



News published on and distributed by: